Avian metapneumovirus excretion in vaccinated and non-vaccinated specified pathogen free laying chickens.
Vaccinated and non-vaccinated specified pathogen-free White Leghorn laying chickens were challenged at peak of lay by the intravenous or oculonasal route with a virulent avian metapneumovirus (aMPV) subtype B chicken strain. Severe clinical signs and a drop in egg production were induced in the non-vaccinated intravenously challenged birds whereas the vaccinates were not affected. Live virus excretion was demonstrated in the faeces and respiratory tract of non-vaccinated hens for up to 7 days post intravenous challenge. After oculonasal challenge, virus excretion could only be demonstrated in the respiratory tract for up to 5 days. No live virus excretion was found in either the faeces or the respiratory tract of vaccinated birds. Concurrent with live virus isolation, the presence of viral RNA was demonstrated by single reverse transcription-polymerase chain reaction (RT-PCR). Nested RT-PCR was more sensitive and viral RNA could be detected in non-vaccinated birds up to 28 days post either intravenous or oculonasal challenge, at which time the experiment was terminated. Viral RNA was detected for up to 12 days in vaccinated birds. This is the first study investigating excretion of aMPV and viral RNA in vaccinated and non-vaccinated laying hens challenged under experimental conditions. The results are of importance with regard to the persistence of aMPV and the appropriate diagnostic detection method in laying birds.
Hess
M
M
Intervet, UK, The Elms, Houghton, Huntingdon, UK.
Huggins
M B
MB
Mudzamiri
R
R
Heincz
U
U
D000818:Animals; D002645:Chickens; D005243:Feces / Q000821:virology; D005260:Female; D029121:Metapneumovirus / Q000276:immunology* / Q000302:isolation & purification / Q000472:pathogenicity; D010058:Oviposition / Q000187:drug effects; D018184:Paramyxoviridae Infections / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D011201:Poultry Diseases / Q000276:immunology / Q000517:prevention & control*; D012367:RNA, Viral / Q000302:isolation & purification; D011897:Random Allocation; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000662:veterinary; D013047:Specific Pathogen-Free Organisms; D013997:Time Factors; D014765:Viral Vaccines / Q000008:administration & dosage*; D014774:Virulence; D017201:Virus Shedding
D012367:RNA, Viral; D014765:Viral Vaccines